Austar Lifesciences Limited

HK$0.54As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6118Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (9.09%)
Div yield —
ROE 2.21%
Medical Devices
Beta (5Y) 0.96
PE TTM 13.76
TSR TTM (50.46%)
Mkt cap HK$274.2M
ROIC 2.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.534
(0.24%)
188.81%
Sell 3|2|7|2|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
6.99%
14.69%
19.77%
7.78%
Revenue¥M
13.10
13.66
13.49
13.35
6.00%
4.82%
2.16%
1.37%
Peers (US$34.98M)
Cap (US$)
PE
58.52M
4.683x
36.31M
—
Capital
TTM
5Y
10Y
Leveragex
0.652
0.145
0.146
EBIT/Intx
0.522
0.661
0.564
Own earn%
48.17
(25.61)
(26.78)
Sh yield%
23.44
5.27
6.06
Owners
Insiders/Inst%
3.47
37.19
Short interest%
4.79
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
1–5
$1 testx
—
Incr. ROIC%
4